What UE LifeSciences does
Founded in 2009, UE LifeSciences operates in the health technology sector, focusing on innovative solutions for early cancer detection. The company initially centered on the development of non-invasive breast cancer screening devices and has since expanded its product offerings to enhance accessibility and affordability of cancer screening, particularly in emerging markets. A notable milestone came in 2016 with the launch of the iBreastExam, a handheld device that allows for quick, radiation-free breast examinations. The company has extended its reach across various global markets, leveraging partnerships with healthcare providers to increase the deployment of its technology. Competitively, UE LifeSciences stands alongside startups like Niramai and ThermaLytix, which are also innovating in the early cancer detection space using non-invasive technologies.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about UE LifeSciences yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.